We are live on ! Find out more
WLYB icon

John Wiley & Sons Class B

10 hedge funds and large institutions have $5.32M invested in John Wiley & Sons Class B in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

5% more capital invested

Capital invested by funds: $5.09M → $5.32M (+$231K)

0.03% more ownership

Funds ownership: 1.05%1.09% (+0.03%)

0% more funds holding

Funds holding: 1010 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

WLYB Hedge Fund Activity: Q3 2017 in Review

10 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in John Wiley & Sons Class B (WLYB) for Q3 2017, worth a combined $5.32M — up 4.5% from $5.09M a quarter earlier.

Fund positioning in WLYB was balanced in Q3 2017: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $160K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $6K sold.

  • 10 institutional investors held John Wiley & Sons Class B (WLYB) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $5.32M of John Wiley & Sons Class B stock for Q3 2017, up 4.5% quarter-over-quarter.
  • 1 fund opened new John Wiley & Sons Class B positions in Q3 2017 and 1 closed out, a net change of 0 holders.
  • The largest John Wiley & Sons Class B buyer in Q3 2017 was Morgan Stanley, an estimated $160K added.
  • The largest John Wiley & Sons Class B seller in Q3 2017 was Tower Research Capital (TRC), an estimated $6K sold.

Based on aggregated 13F filings for Q3 2017.